Personalized brain stimulation could help researchers investigate cognitive difficulties that persist when bipolar mood symptoms are stable. A new study in npj Mental Health Research examines how repetitive transcranial magnetic stimulation, or rTMS, and transcranial alternating current stimulation, or tACS, relate to changes in brain networks.
The central question is whether those changes help explain cognitive outcomes. Detecting a biological response is an important research step, but establishing meaningful improvement in memory, attention, or everyday functioning requires additional evidence.
Cognitive Symptoms Beyond Mood Episodes
Treating mood episodes does not necessarily resolve cognitive difficulties. Memory, learning, and executive function can remain impaired during remission, while existing pharmacological, psychological, and behavioral approaches produce uneven results.
An earlier randomized trial published in BMC Medicine investigated individualized stimulation for this problem. Researchers used diffusion tensor imaging, which maps white matter pathways, to select a prefrontal target connected to the dorsal anterior cingulate cortex.
The protocol combined personalized tACS with navigated rTMS. Of 100 randomized participants, 66 completed treatment. The combined group showed greater improvement on several cognitive tests after three weeks, providing a rationale for examining the underlying network response.
Brain Stimulation In Bipolar II Disorder Shows Distinct Network Patterns
The new secondary imaging analysis included 52 euthymic participants with bipolar II disorder, meaning their mood symptoms were relatively stable. Over three weeks, 16 received combined stimulation, 14 received rTMS, 13 received tACS, and nine received sham treatment.
All active conditions targeted an individualized location in the left dorsolateral prefrontal cortex.
Researchers combined electric field modeling with degree centrality, an imaging measure of how extensively a brain location connects functionally with other locations.
Compared with sham, all three active conditions showed changes converging in the left rolandic operculum. The rTMS comparison also identified changes in parahippocampal and middle occipital regions.
These findings suggest partly distinct network responses across stimulation approaches.
Network Changes Require Careful Interpretation
Associations between network changes and cognitive outcomes did not survive correction for multiple comparisons. Neither did exploratory mediation results testing whether network changes might connect electric field intensity with cognitive change.
One association did survive correction: electric field intensity was related to a network–cognition coupling index in the left caudate within the tACS group.
That finding concerns a statistical relationship between measurements. It does not establish that stronger stimulation improves cognition or that the caudate mediates treatment benefit.
Two Stimulation Methods, Different Biological Levers
rTMS uses magnetic pulses to induce electrical activity in targeted brain tissue. tACS delivers an alternating electrical current through scalp electrodes, with the aim of influencing rhythmic neural activity.
The earlier protocol applied 40-Hz tACS before navigated rTMS. Individual head models helped optimize electrical stimulation and coil orientation.
This approach addresses a practical challenge: the device setting alone does not fully describe the stimulation reaching a particular brain region. Anatomy and positioning influence the resulting electric field.
Modeling therefore offers a way to investigate differences in exposure. It remains an estimate of stimulation delivery, rather than a direct measurement of therapeutic benefit.
A Framework For Testing Personalized Treatment
The distinctive contribution is the attempt to connect three levels of measurement: modeled stimulation exposure, network response, and cognition.
Each level answers a different question. Did stimulation reach the intended tissue? Did brain activity change? Did the participant perform better? A convincing treatment mechanism requires those answers to fit together reproducibly.
For clinicians, this framework may eventually help refine targeting and dosing. For patients, the immediate implication is more limited: a measurable brain response does not yet tell researchers who will experience lasting cognitive improvement.
From Network Signals To Clinical Evidence
The next step is prospective testing in larger samples, with predefined analyses and follow-up that captures everyday functioning. Replication should establish whether the observed relationships predict benefit beyond the treatment period.
The study advances a testable direction for personalized neuromodulation. Its network findings help frame future experiments while leaving the clinical value of those changes unresolved.
Citations
- Qi S, Tang R, Zhang X, et al. Cognitive changes following rTMS, tACS, and their combination in bipolar II disorder: an exploratory study integrating degree centrality and individualized electric field modeling. npj Mental Health Research. 2026.
- Wang M, Zhou H, Zhang X, et al. Alleviating cognitive impairments in bipolar disorder with a novel DTI-guided multimodal neurostimulation protocol: a double-blind randomized controlled trial. BMC Medicine. 2025.
Explore more at Interventional Psychiatry Network.
